An Evaluation of California's Experiment With HOPE

April 6, 2018 updated by: Pepperdine University

Phase 1 Study of California's HOPE Experiment

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.

Study Type

Interventional

Enrollment (Anticipated)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Sacramento, California, United States, 95811
        • Sacramento Metro IV Parole Unit.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Assigned to the Sacramento Metro IV Parole Unit.
  • Released from a term of return-to-custody for a violation for, or involving, the use of drugs.
  • Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

Exclusion Criteria:

  • History of convictions for crimes that require registration under Penal Code Section 290.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HOPE supervision
Parolee supervised under California's new HOPE parole model.
Behavioral: HOPE supervision
HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.
Other Names:
  • HOPE
  • COPE
Active Comparator: Parole-as-usual
Parolees supervised under California parole-as-usual.
Behavioral: Parole-as-usual
Parolees are supervised under standard parole supervision practice in California.
Other Names:
  • Routine parole

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days incarcerated
Time Frame: 24 months
Total number of days incarcerated in jail or prison
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% positive drug tests
Time Frame: 24 months
Percentage of random and scheduled drug tests that test positive for illicit drugs
24 months
%Missed
Time Frame: 24 months
Percentage of parole appointments that are missed.
24 months
Revocation rate
Time Frame: 24 months
Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.
24 months
New arrests
Time Frame: 24 months
Number of new arrests.
24 months
Perceptions of risk of detection
Time Frame: 24 months
Parolees perceived risk of detection for drug use
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pepperdine University

Collaborators

University of California, Los Angeles
University of California, Irvine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2010

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

November 1, 2010

First Submitted That Met QC Criteria

November 8, 2010

First Posted (Estimate)

November 9, 2010

Study Record Updates

Last Update Posted (Actual)

April 10, 2018

Last Update Submitted That Met QC Criteria

April 6, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SPPN1110F01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drugs of Abuse

Clinical Trials on HOPE supervision

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe